Written Question: Commission actions to complement national policies on the treatment of endometriosis and improve access to treatment for all women in the EU
(Source: European Parliament)
Date submitted: 17 March 2021
Question for written answer E-001458/2021/rev.1
to the Commission
Leszek Miller (S&D)
Subject: Commission actions to complement national policies on the treatment of endometriosis and improve access to treatment for all women in the EU
Endometriosis is a dangerous disorder of the lining of the uterus that affects millions of women across the EU. The health effects of this disease are very significant, its course is often painful and it can be associated with infertility. Between 10% and 15% of women of reproductive age suffer from this disease, but, for a variety of reasons, precise diagnoses that could lead to effective treatment are delayed for years. As a result, patients are usually diagnosed when the disease has reached an advanced stage, which makes it impossible to begin optimal treatment of the disease.
Unfortunately, in many Member States, including Poland, there is no programme for the effective treatment of endometriosis because it is not recognised as a chronic disease. Moreover, operations for the condition, which are long, difficult and expensive, are mainly performed in the private sector. This entails very high costs that few people can afford. On the other hand, in some Member States (e.g. Denmark) patients do receive the necessary help, as reference treatment centres and extensive counselling are available.
Given that endometriosis is a disease which, without appropriate treatment or surgery, has a chronic and negative impact on the lives of millions of women in the EU, will the Commission take action aimed at supporting the standardisation of the treatment of endometriosis in the EU and making it more accessible to all women?